Beam Therapeutics
Massachusetts, United States
101-250 Employees
Automotive
•Healthcare
•Tech
Supply Chain Co-Op
--
Description
Beam Therapeutics (NASDAQ: BEAM) is a cutting-edge biotechnology company that is revolutionizing the field of genetic medicine. Founded in 2017, Beam is at the forefront of developing innovative base editing technology that enables precise, single-letter editing of DNA, offering the potential to treat a wide range of genetic diseases. With a strong focus on precision and efficiency, Beam Therapeutics is leading the way in creating next-generation therapies that could transform the future of...
Financials
Type
public
Annual Revenue
--
Market Cap
$2.4B+
Subscribe to Refer Me premium to get referred to this role at Beam Therapeutics!
